(S (NP-SBJ (NP (JJ Human) (NN immunodeficiency) (NNS viruses)) (VP (VBG containing) (NP (JJ heterologous) (NNS (promoters enhancer))))) (VP-COOD (VP (VBP are) (ADJP-PRD (NN replication) (JJ competent))) (CC and) (VP (VBP exhibit) (NP (JJ different) (NN lymphocyte) (NNS tropisms)))) (. .))
(S (NP-SBJ (DT The) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NN type) (CD 1) (NP (NP (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-)))) (VP (VBZ contains) (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (NP-COOD (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (CC and) (NP (DT the) (ADJP (RB constitutively) (VBN expressed)) (NN transcription) (NN factor) (NN Sp1))) (, ,) (SBAR (WHNP-59 (NP (DT both)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ-60 (-NONE- *T*-59)) (VP (VBP are) (VP (ADVP (RB highly)) (VBN conserved) (NP (-NONE- *-60)) (PP (IN in) (NP (NP-COOD (NP (NN HIV)) (CC and) (NP (JJ simian) (NN immunodeficiency) (NN virus))) (NNS isolates))))))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP-COOD (VP (TO To) (VP (VB delineate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT these) (NNS motifs))) (PP (IN on) (NP (NP (DT the) (JJ replicative) (NN capacity)) (PP (IN of) (NP (NN HIV)))))))) (CC and) (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN possibility)) (PP (IN of) (S (NP-SBJ (-NONE- *)) (VP (VBG extending) (NP (DT the) (NN virus) (NN host) (NN range)))))))))) (, ,) (NP-SBJ-61 (VBN known) (JJ heterologous) (NNS (promoters enhancer))) (VP (VBD were) (VP (VBN inserted) (NP (-NONE- *-61)) (PP (IN into) (NP (DT the) (NN HIV-1) (NN LTR))) (PP (IN in) (NN place) (IN of) (NP (DT the) (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN Sp1))) (NN binding) (NNS sites))))) (. .))
(S (NP-SBJ-62 (NP (DT The) (NNS effects)) (PP (IN of) (NP (DT these) (NNS substitutions))) (PP-COOD (PP (IN on) (NP (NP (JJ viral) (NN replication)) (PP (IN in) (NP (VBN transfected) (NN HeLa) (NNS cells))))) (CC and) (PP (IN on) (NP (NP (NN HIV) (NN infection)) (PP (IN of) (NP-COOD (NP (JJ human) (JJ peripheral) (NN blood) (NNS lymphocytes)) (CC or) (NP (JJ continuous) (NN T-leukemia) (NN cell) (NNS lines)))))))) (VP (VBD were) (VP (VBN evaluated) (NP (-NONE- *-62)))) (. .))
(S (NP-SBJ-63 (NP (NN HIVs)) (SBAR (WHPP-64 (IN in) (WHNP (WDT which))) (S (NP-SBJ-COOD-65 (NP (DT the) (NN NF-) (NN kappa) (NN (Sp1 B)) (NN enhancer)) (CC plus) (NP (DT the) (JJ downstream) (NN TATA) (NN element))) (VP (VBD were) (VP (VBN replaced) (NP (-NONE- *-65)) (PP (IN with) (NP (JJ heterologous) (NNS (promoters enhancer)))) (PP (-NONE- *T*-64))))))) (VP (VBD were) (VP (ADVP (RB also)) (VBN constructed) (NP (-NONE- *-63)))) (. .))
(S (NP-SBJ (NP (NNS Viruses)) (VP (VBG containing) (NP (DT the) (JJ human) (NN cytomegalovirus) (JJ immediate-early) (NN enhancer)))) (VP-COOD (VP (VBD exhibited) (NP (NP (JJ infectious) (NNS kinetics)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (JJ wild-type) (NN HIV))))))) (PP (IN in) (NP-COOD (NP (VBN activated) (JJ human) (JJ peripheral) (NN blood) (NNS lymphocytes)) (CC and) (NP (NN AA2) (NNS cells))))) (CC but) (VP (VBD replicated) (ADVP (RBR less) (RB efficiently)) (PP (IN in) (NP (NP-COOD (NP (NN H9)) (CC and) (NP (NN CEM))) (NNS cells))))) (. .))
(S (NP-SBJ (DT These) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-103 (JJ heterologous) (NN enhancer) (NNS elements)) (VP (VBP are) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ-104 (-NONE- *-103)) (VP (VBG restoring) (NP (NP (NN Tat) (NN responsiveness)) (PP (TO to) (NP (DT the) (NN HIV) (NN LTR)))) (PP-COOD (PP (IN in) (DT the) (NN context) (IN of) (S (NP-SBJ (-NONE- *-104)) (VP (VBG directing) (NP (NN reporter) (NN gene) (NN expression))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (JJ infectious) (NN progeny) (NNS virions)))))))))))))) (. .))
